Goldman Sachs’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Sell |
156,572
-399,381
| -72% | -$567K | ﹤0.01% | 4677 |
|
|
2025
Q1 | $851K | Buy |
555,953
+127,366
| +30% | +$195K | ﹤0.01% | 3925 |
|
|
2024
Q4 | $1.06M | Buy |
428,587
+127,031
| +42% | +$315K | ﹤0.01% | 3882 |
|
|
2024
Q3 | $347K | Sell |
301,556
-615,064
| -67% | -$707K | ﹤0.01% | 4282 |
|
|
2024
Q2 | $1.01M | Buy |
916,620
+770,808
| +529% | +$848K | ﹤0.01% | 3578 |
|
|
2024
Q1 | $181K | Sell |
145,812
-375,068
| -72% | -$465K | ﹤0.01% | 4358 |
|
|
2023
Q4 | $547K | Buy |
520,880
+248,059
| +91% | +$260K | ﹤0.01% | 3899 |
|
|
2023
Q3 | $1.87M | Sell |
272,821
-116,965
| -30% | -$801K | ﹤0.01% | 3135 |
|
|
2023
Q2 | $4.04M | Buy |
389,786
+93,144
| +31% | +$966K | ﹤0.01% | 2713 |
|
|
2023
Q1 | $2.4M | Sell |
296,642
-50,656
| -15% | -$410K | ﹤0.01% | 3090 |
|
|
2022
Q4 | $5.47M | Sell |
347,298
-74,949
| -18% | -$1.18M | ﹤0.01% | 2551 |
|
|
2022
Q3 | $6.65M | Buy |
422,247
+14,358
| +4% | +$226K | ﹤0.01% | 2438 |
|
|
2022
Q2 | $5.69M | Buy |
407,889
+149,430
| +58% | +$2.09M | ﹤0.01% | 2555 |
|
|
2022
Q1 | $4.46M | Buy |
258,459
+37,267
| +17% | +$643K | ﹤0.01% | 2893 |
|
|
2021
Q4 | $3.22M | Sell |
221,192
-219,902
| -50% | -$3.2M | ﹤0.01% | 3133 |
|
|
2021
Q3 | $7.94M | Buy |
441,094
+115,819
| +36% | +$2.08M | ﹤0.01% | 2448 |
|
|
2021
Q2 | $5.71M | Buy |
325,275
+204,693
| +170% | +$3.59M | ﹤0.01% | 2682 |
|
|
2021
Q1 | $3.04M | Buy |
120,582
+94,275
| +358% | +$2.38M | ﹤0.01% | 3028 |
|
|
2020
Q4 | $170K | Hold |
26,307
| – | – | ﹤0.01% | 4324 |
|
|
2020
Q3 | $68K | Sell |
26,307
-8,805
| -25% | -$22.8K | ﹤0.01% | 4285 |
|
|
2020
Q2 | $57K | Buy |
35,112
+11,026
| +46% | +$17.9K | ﹤0.01% | 4242 |
|
|
2020
Q1 | $25K | Sell |
24,086
-21,623
| -47% | -$22.4K | ﹤0.01% | 4336 |
|
|
2019
Q4 | $86K | Buy |
45,709
+3,767
| +9% | +$7.09K | ﹤0.01% | 4150 |
|
|
2019
Q3 | $46K | Sell |
41,942
-119,270
| -74% | -$131K | ﹤0.01% | 4132 |
|
|
2019
Q2 | $353K | Buy |
161,212
+64,376
| +66% | +$141K | ﹤0.01% | 3655 |
|
|
2019
Q1 | $580K | Sell |
96,836
-27,944
| -22% | -$167K | ﹤0.01% | 3505 |
|
|
2018
Q4 | $922K | Buy |
124,780
+29,342
| +31% | +$217K | ﹤0.01% | 3158 |
|
|
2018
Q3 | $1.39M | Buy |
95,438
+26,337
| +38% | +$382K | ﹤0.01% | 3040 |
|
|
2018
Q2 | $1.38M | Sell |
69,101
-30,321
| -30% | -$606K | ﹤0.01% | 3048 |
|
|
2018
Q1 | $1.74M | Buy |
99,422
+27,810
| +39% | +$487K | ﹤0.01% | 2943 |
|
|
2017
Q4 | $1.77M | Sell |
71,612
-21,143
| -23% | -$521K | ﹤0.01% | 2891 |
|
|
2017
Q3 | $2.39M | Buy |
92,755
+12,727
| +16% | +$328K | ﹤0.01% | 2775 |
|
|
2017
Q2 | $2.17M | Buy |
80,028
+45,305
| +130% | +$1.23M | ﹤0.01% | 2753 |
|
|
2017
Q1 | $1.04M | Buy |
+34,723
| New | +$1.04M | ﹤0.01% | 3088 |
|